Posts In: Gubba Pharma In E News

DuPont, BioMe Oxford to co-develop and bring to market smart capsule to sample gut microbiota

June 19, 2019 Gubba Pharma In E News

Intestinal microbiome, 3D illustration showing anatomy of human digestive system and enteric bacteria Escherichia coli, E. coli, colonizing jejunum, ileum, other parts of intestine. Gut...

Continue Reading

Pfizer opens new biologics clinical manufacturing facility in Massachusetts

June 12, 2019 Gubba Pharma In E News

Pfizer’s Andover site houses commercial manufacturing and product development functions, with colleagues dedicated to the development and production of high-quality complex biologics and vaccines. With...

Continue Reading

New Data Show Use of Abbott’s FreeStyle® Libre System Significantly Reduces HbA1c Levels in People Living with Type 2 Diabetes

June 12, 2019 Gubba Pharma In E News

Presented as a late-breaker at the American Diabetes Association (ADA) 79th Scientific Sessions, new real-world data demonstrate that monitoring glucose with FreeStyle Libre System has...

Continue Reading

Consultation on draft guideline on quality requirements for medical devices in combination products

June 6, 2019 Gubba Pharma In E News

EMA has released a draft guideline on the quality requirements for medical devices in human medicines that include a medical device, known as drug-device combinations,...

Continue Reading

At $2M, priciest ever medicine treats fatal genetic disease

June 6, 2019 Gubba Pharma In E News

U.S. regulators have approved the most expensive medicine ever, for a rare disorder that destroys a baby’s muscle control and kills nearly all of those...

Continue Reading

Thermo Fisher Scientific inaugurates new facility in Ahmedabad

May 28, 2019 Gubba Pharma In E News

The state-of-the art facility in the domestic tariff area (DTA) is part of Thermo Fisher’s clinical trials business and was built to help address the...

Continue Reading

Shilpa Medicare gets USFDA nod for cancer treatment injection

May 28, 2019 Gubba Pharma In E News

Shilpa Medicare said it has received approval from the US health regulator for Irinotecan HCL injection, used for treatment of certain kind of cancers.  The company has...

Continue Reading

Phytotech Extracts invests Rs.12 crore for advanced phyto extracts unit in Karnataka to bolster its foray into global markets

May 28, 2019 Gubba Pharma In E News

Phytotech Extracts has invested Rs.12 crore via the self funded route for its new facility to foray into the global markets as a phyto extracts company....

Continue Reading

Indian generic industry loses a titan in DG Shah

March 28, 2019 Gubba Pharma In E News

D G Shah had a larger imprint on the pharma industry than what his job title — secretary general of the Indian Pharmaceutical Alliance (IPA)...

Continue Reading